Global Fibrinogen Concentrate Market by indication (Congenital Fibrinogen Deficiency and Surgical Procedure), Regional Forecasts 2021-2027
- Category: Healthcare
- Published Date: Oct 2021
- Publisher: Bizwit Research
- Pages: 200
Global Fibrinogen Concentrate Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2021-2027. Fibrinogen, a glycoprotein present in blood plasma of vertebrates generated by the liver, helps in the development of blood clots. Due to a low level of fibrinogen, blood clots can develop inside blood vessels, causing thrombosis, which disrupts normal blood flow through the circulatory system. It's also utilized to make blood-related medicines. Thrombosis is an uncommon bleeding condition that can range in severity from moderate to severe. Afibrinogenemia, hypofibrinogenemia, and dysfibrinogenemia are the three forms of fibrinogen deficiencies. The rising prevalence of bleeding disorders, as well as an increase in the number of approvals for fibrinogen concentrate, are key contributors to the market's growth. According to a research conducted by the United Kingdom Doctor's Hemophilia Association, there were about 11,089 persons in the United Kingdom with coagulation abnormalities in 2018. In addition, LFB gained regulatory permission in Europe to commercialize the FibClot product in 2016. As a result, demand for fibrinogen concentrate is projected to increase. However, stringent regulatory framework may impede market growth over the forecast period of 2021-2027.
In 2020, Europe accounted for the largest share of the worldwide fibrinogen concentrates market, followed by North America. During the projection period, Europe is anticipated to maintain its market share. The market in the region is driven by a high level of knowledge about the availability of various brands of fibrinogen concentrate products and the early launch of fibrinogen concentrates. During the projection period, Asia Pacific is expected to increase market share. Product launches, acquisitions, distribution agreements, alliances, and regional growth by companies are expected to drive the fibrinogen concentrates market in the region, particularly in China and Japan.
Major market player included in this report are:
LFB Group
CSL Behring
Profibrix Bv
Shanghai Xinxing Medicine Co. Ltd.
Baxter International Inc.
Shanghai RAAS
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical Co. Ltd.
Green Cross International
Jiangxi Boya Bio-Pharmaceutical
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Congenital Fibrinogen Deficiency
Surgical Procedure
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Fibrinogen Concentrate Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
In 2020, Europe accounted for the largest share of the worldwide fibrinogen concentrates market, followed by North America. During the projection period, Europe is anticipated to maintain its market share. The market in the region is driven by a high level of knowledge about the availability of various brands of fibrinogen concentrate products and the early launch of fibrinogen concentrates. During the projection period, Asia Pacific is expected to increase market share. Product launches, acquisitions, distribution agreements, alliances, and regional growth by companies are expected to drive the fibrinogen concentrates market in the region, particularly in China and Japan.
Major market player included in this report are:
LFB Group
CSL Behring
Profibrix Bv
Shanghai Xinxing Medicine Co. Ltd.
Baxter International Inc.
Shanghai RAAS
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical Co. Ltd.
Green Cross International
Jiangxi Boya Bio-Pharmaceutical
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Congenital Fibrinogen Deficiency
Surgical Procedure
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Fibrinogen Concentrate Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Fibrinogen Concentrate Market, by Region, 2019-2027 (USD Billion)
1.2.2. Fibrinogen Concentrate Market, by Indication, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Fibrinogen Concentrate Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Fibrinogen Concentrate Market Dynamics
3.1. Fibrinogen Concentrate Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing product approvals
3.1.1.2. Increasing burden of blood disorders
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory framework
3.1.3. Market Opportunities
3.1.3.1. Rise in demand for fibrinogen among physicians
Chapter 4. Global Fibrinogen Concentrate Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Fibrinogen Concentrate Market, by Indication
5.1. Market Snapshot
5.2. Global Fibrinogen Concentrate Market by Indication, Performance - Potential Analysis
5.3. Global Fibrinogen Concentrate Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
5.4. Fibrinogen Concentrate Market , Sub Segment Analysis
5.4.1. Congenital Fibrinogen Deficiency
5.4.2. Surgical Procedure
Chapter 6. Global Fibrinogen Concentrate Market, Regional Analysis
6.1. Fibrinogen Concentrate Market , Regional Market Snapshot
6.2. North America Fibrinogen Concentrate Market
6.2.1. U.S. Fibrinogen Concentrate Market
6.2.1.1. Indication breakdown estimates & forecasts, 2018-2027
6.2.2. Canada Fibrinogen Concentrate Market
6.3. Europe Fibrinogen Concentrate Market Snapshot
6.3.1. U.K. Fibrinogen Concentrate Market
6.3.2. Germany Fibrinogen Concentrate Market
6.3.3. France Fibrinogen Concentrate Market
6.3.4. Spain Fibrinogen Concentrate Market
6.3.5. Italy Fibrinogen Concentrate Market
6.3.6. Rest of Europe Fibrinogen Concentrate Market
6.4. Asia-Pacific Fibrinogen Concentrate Market Snapshot
6.4.1. China Fibrinogen Concentrate Market
6.4.2. India Fibrinogen Concentrate Market
6.4.3. Japan Fibrinogen Concentrate Market
6.4.4. Australia Fibrinogen Concentrate Market
6.4.5. South Korea Fibrinogen Concentrate Market
6.4.6. Rest of Asia Pacific Fibrinogen Concentrate Market
6.5. Latin America Fibrinogen Concentrate Market Snapshot
6.5.1. Brazil Fibrinogen Concentrate Market
6.5.2. Mexico Fibrinogen Concentrate Market
6.6. Rest of The World Fibrinogen Concentrate Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. LFB Group
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. CSL Behring
7.2.3. Profibrix Bv
7.2.4. Shanghai Xinxing Medicine Co. Ltd.
7.2.5. Baxter International Inc.
7.2.6. Shanghai RAAS
7.2.7. Hualan Biological Engineering
7.2.8. Harbin Pacific Biopharmaceutical Co. Ltd.
7.2.9. Green Cross International
7.2.10. Jiangxi Boya Bio-Pharmaceutical
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Fibrinogen Concentrate Market, by Region, 2019-2027 (USD Billion)
1.2.2. Fibrinogen Concentrate Market, by Indication, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Fibrinogen Concentrate Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Fibrinogen Concentrate Market Dynamics
3.1. Fibrinogen Concentrate Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing product approvals
3.1.1.2. Increasing burden of blood disorders
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory framework
3.1.3. Market Opportunities
3.1.3.1. Rise in demand for fibrinogen among physicians
Chapter 4. Global Fibrinogen Concentrate Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Fibrinogen Concentrate Market, by Indication
5.1. Market Snapshot
5.2. Global Fibrinogen Concentrate Market by Indication, Performance - Potential Analysis
5.3. Global Fibrinogen Concentrate Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
5.4. Fibrinogen Concentrate Market , Sub Segment Analysis
5.4.1. Congenital Fibrinogen Deficiency
5.4.2. Surgical Procedure
Chapter 6. Global Fibrinogen Concentrate Market, Regional Analysis
6.1. Fibrinogen Concentrate Market , Regional Market Snapshot
6.2. North America Fibrinogen Concentrate Market
6.2.1. U.S. Fibrinogen Concentrate Market
6.2.1.1. Indication breakdown estimates & forecasts, 2018-2027
6.2.2. Canada Fibrinogen Concentrate Market
6.3. Europe Fibrinogen Concentrate Market Snapshot
6.3.1. U.K. Fibrinogen Concentrate Market
6.3.2. Germany Fibrinogen Concentrate Market
6.3.3. France Fibrinogen Concentrate Market
6.3.4. Spain Fibrinogen Concentrate Market
6.3.5. Italy Fibrinogen Concentrate Market
6.3.6. Rest of Europe Fibrinogen Concentrate Market
6.4. Asia-Pacific Fibrinogen Concentrate Market Snapshot
6.4.1. China Fibrinogen Concentrate Market
6.4.2. India Fibrinogen Concentrate Market
6.4.3. Japan Fibrinogen Concentrate Market
6.4.4. Australia Fibrinogen Concentrate Market
6.4.5. South Korea Fibrinogen Concentrate Market
6.4.6. Rest of Asia Pacific Fibrinogen Concentrate Market
6.5. Latin America Fibrinogen Concentrate Market Snapshot
6.5.1. Brazil Fibrinogen Concentrate Market
6.5.2. Mexico Fibrinogen Concentrate Market
6.6. Rest of The World Fibrinogen Concentrate Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. LFB Group
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. CSL Behring
7.2.3. Profibrix Bv
7.2.4. Shanghai Xinxing Medicine Co. Ltd.
7.2.5. Baxter International Inc.
7.2.6. Shanghai RAAS
7.2.7. Hualan Biological Engineering
7.2.8. Harbin Pacific Biopharmaceutical Co. Ltd.
7.2.9. Green Cross International
7.2.10. Jiangxi Boya Bio-Pharmaceutical
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption
no record found